share_log

Moleculin Biotech | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Foster Jonathan P.

SEC ·  Jun 22, 2023 19:02
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more